Eisai
4523.T
#2008
Rank
S$12.08 B
Marketcap
S$42.89
Share price
-0.53%
Change (1 day)
10.49%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. In 2026 the company made an earnings per share (EPS) of S$1.11 a decrease over its 2025 EPS that were of S$1.41.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026S$1.11-21.04%
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.875.52%
2022S$1.77-74.01%
2021S$6.82-66.58%
2020S$20.4098.24%
2019S$10.2917.01%
2018S$8.7937.78%
2017S$6.38-27.62%
2016S$8.8235.33%
2015S$6.52-2.82%
2014S$6.71-27.66%
2013S$9.27-27.49%
2012S$12.79-12.67%
2011S$14.6488.08%
2010S$7.78-11.06%
2009S$8.75-390.15%
2008S-$3.02-127.78%
2007S$10.86347.11%
2006S$2.434.38%
2005S$2.337.4%
2004S$2.1743.03%
2003S$1.5225.09%
2002S$1.2152.67%
2001S$0.7969.76%
2000S$0.47